Vaxcyte (PCVX) Receivables (2021 - 2024)
Vaxcyte (PCVX) posted quarterly Receivables of $17.9 million for Q3 2024, up 235.69% year-over-year from $5.3 million in Q4 2023, and up 111.0% quarter-over-quarter from $8.5 million in Q2 2024.
Vaxcyte (PCVX) Receivables (2021 - 2024) Analysis & Trends
Vaxcyte (PCVX) has reported Receivables for 4 consecutive years, with $17.9 million the latest figure, recorded in Q3 2024.
- In Q3 2024, Receivables rose 235.69% year-over-year to $17.9 million; the TTM figure through Sep 2024 stood at $17.9 million (up 235.69% YoY), while the FY2023 annual figure was $3.6 million, down 6.96% from the prior year.
- Receivables grew to $17.9 million in Q3 2024 per PCVX's latest filing, from $8.5 million in the prior quarter.
- Across five years, Receivables topped out at $17.9 million in Q3 2024 and bottomed at $3.6 million in Q4 2023.
- Historically, Receivables has averaged $7.5 million across 4 years, with a median of $5.3 million in 2023.
- Annual changes were most pronounced in 2023 — Receivables slipped 6.96% — and 2024, when it soared 235.69%.
- Vaxcyte's Receivables stood at $5.0 million in 2021, then declined by 22.46% to $3.9 million in 2022, then slipped by 6.96% to $3.6 million in 2023, then soared by 395.48% to $17.9 million in 2024.
- Business Quant data shows PCVX's Receivables at $17.9 million in Q3 2024, $8.5 million in Q2 2024, and $8.1 million in Q1 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 2.13 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 6.57 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.93 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 1.06 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 1.84 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 912.74 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 215.33 Mn |
| 10 | Vaxcyte | 8.41 Bn | 8.41 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | 17.87 Mn |
| Jun 30, 2024 | 8.47 Mn |
| Mar 31, 2024 | 8.15 Mn |
| Dec 31, 2023 | 3.61 Mn |
| Sep 30, 2023 | 5.32 Mn |
| Dec 31, 2022 | 3.88 Mn |
| Sep 30, 2021 | 5.00 Mn |